ORGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Organogenesis Holdings Inc (ORGO) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite a slight pre-market price drop, the company's strong financial performance, positive growth trends, and favorable analyst rating support a long-term investment decision.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 65.966, and moving averages are converging, suggesting consolidation. Key support is at 2.246, and resistance is at 2.588, with the pre-market price of 2.55 near resistance levels.
Strong financial performance in Q4 2025, with revenue up 78.13% YoY, net income up 497.82% YoY, and EPS up 400% YoY. Gross margin also improved to 77.87%. Analyst maintains a Buy rating despite lowering the price target to $8.
No recent news or significant insider/hedge fund trading activity. Pre-market price is down 0.78%, and the stock has a 60% chance to decline 0.92% in the next day.
In Q4 2025, revenue increased to $225.6M (+78.13% YoY), net income rose to $35.1M (+497.82% YoY), EPS improved to $0.25 (+400% YoY), and gross margin expanded to 77.87% (+3.17% YoY).
BTIG maintains a Buy rating but lowered the price target from $9 to $8, citing a 'new economic reality' despite a strong quarter.
